2 results
Approved WMORecruiting
The purpose of this scientific study is to verify whether immunotherapy (L19-IL2) after a standard treatment such as radiotherapy, fights the metastatic disease more efficiently than the current standard treatment alone.
Approved WMOCompleted
To determine the safety and tolerability of L19-IL2 combined with SABR.